BioPharma Resources

Drug Trial Radar · NCT07288138

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a THRβ Agonist (ECC4703), an SSAO Inhibitor (ECC0509), and Their Combination in Adults With Presumed MASH

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Dec 15, 2025

Primary completion

Sep 15, 2027

Study completion Sep 29, 2027

Sponsor

Lead sponsor
EccogeneIndustry
Sponsor type
Industry
First posted
Dec 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on hepatic fat reduction as assessed by change in magnetic resonance imaging proton density fat fraction (MRI-PDFF) at Week 12.

Conditions

  • Metabolic Dysfunction-associated Steatohepatitis

Interventions

  • PlaceboDrug

    Placebo will be administered as matching oral capsules.

  • ECC4703Drug

    ECC4703 will be administered as oral capsules.

  • ECC0509Drug

    ECC0509 will be administered as oral capsules.

  • ECC4703Drug

    ECC4703 will be administered as oral capsules.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative Change from Baseline in Liver Fat Content by MRI-PDFF, Comparing ECC4703 Monotherapy Versus PlaceboTime frame: Baseline and Week 12

Locations

70 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Liver Health

    Chandler, Arizona · Recruiting

  • Arizona Liver Health - Peoria

    Peoria, Arizona · Recruiting

  • Adobe Clinical Research, LLC

    Tucson, Arizona · Recruiting

  • Arizona Liver Health - Tucson

    Tucson, Arizona · Recruiting

  • Arkansas Gastroenterology, P.A

    Little Rock, Arkansas · Recruiting

  • ARcare Center for Clinical Research

    Little Rock, Arkansas · Recruiting

  • Om Research

    Apple Valley, California · Recruiting

  • ARK Clinical Research - Fountain Valley

    Fountain Valley, California · Recruiting

  • UCSD Medical Center

    La Jolla, California · Recruiting

  • Om Research

    Lancaster, California · Recruiting

  • Ark Clinical Research

    Long Beach, California · Recruiting

  • Knowledge Research Center

    Orange, California · Recruiting

  • Om Research

    Victorville, California · Recruiting

  • Synergy Healthcare

    Bradenton, Florida · Recruiting

  • Synergy Healthcare

    Bradenton, Florida · Recruiting

  • Health Awareness, Inc.

    Jupiter, Florida · Recruiting

  • Evolution Clinical Trials

    Miami, Florida · Recruiting

  • Floridian Clinical Research, LLC

    Miami Lakes, Florida · Recruiting

  • Ocala GI Research

    Ocala, Florida · Recruiting

  • Progressive Medical Research

    Port Orange, Florida · Recruiting

  • ClinCloud, LLC

    Viera, Florida · Recruiting

  • Metabolic Research Institute

    West Palm Beach, Florida · Recruiting

  • CenExel - iResearch

    Decatur, Georgia · Recruiting

  • Gastrointestinal Specialists of Georgia, PC

    Marietta, Georgia · Recruiting

  • GI Alliance Glenview

    Glenview, Illinois · Recruiting

  • GI Alliance Gurnee

    Gurnee, Illinois · Recruiting

  • Digestive Research Alliance of Michiana

    South Bend, Indiana · Active not recruiting

  • Tandem Clinical Research

    Covington, Louisiana · Recruiting

  • Tandem Clinical Research

    Houma, Louisiana · Recruiting

  • Tandem Clinical Research GI, LLC

    Marrero, Louisiana · Recruiting

  • Tandem Clinical Research

    Metairie, Louisiana · Recruiting

  • Delta Research Partners

    Monroe, Louisiana · Recruiting

  • Louisiana Research Center, LLC

    Shreveport, Louisiana · Recruiting

  • Delta Research Partners, LLC

    West Monroe, Louisiana · Recruiting

  • Mid-Atlantic GI Research

    Greenbelt, Maryland · Recruiting

  • Gastrointestinal Associates

    Columbia, Missouri · Recruiting

  • Gateway GI Research, LLC

    St Louis, Missouri · Recruiting

  • Jubilee Clinical Research, Inc

    Las Vegas, Nevada · Recruiting

  • Clinical Research Integrity (CRI) Lifetree, LLC

    Marlton, New Jersey · Recruiting

  • Premier Health Research

    Sparta, New Jersey · Recruiting

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.